Taisie Seigrist, a 15-year-old track and cross-country athlete in Oklahoma, was diagnosed with Type 1 diabetes five years ago ...
Morning Overview on MSN
An old asthma inhaler drug just reversed advanced fatty liver damage in the lab — and doctors are now racing it into human trials
Roughly 115 million adults worldwide are estimated to have metabolic dysfunction-associated steatohepatitis, or MASH, a ...
Enables dosing at the start of a meal, offering flexibility for children and adolescents as they manage school, sports, meals, and snacks ...
Morning Overview on MSN
A sweeping trial of an old asthma inhaler just reversed fatty liver disease in mice — researchers now racing the drug into human trials within the year
An estimated 100 million Americans have some degree of fatty liver disease, and until very recently, not a single drug was ...
Inhaled chronic obstructive pulmonary disease (COPD) medications prescribed before surgery in patients with early-stage non–small cell lung cancer (NSCLC) were associated with both short- and ...
By Sahil Pandey and Sriparna Roy May 29 (Reuters) - The U.S. Food and Drug Administration has approved expanded use of MannKind's inhaled rapid-acting insulin in children with diabetes, offering ...
Please provide your email address to receive an email when new articles are posted on . Less than 40% of the studied veteran cohort were adherent to their inhaled COPD medications. Adherence was found ...
Please provide your email address to receive an email when new articles are posted on . This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled ...
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...
Leah J. Witt, MD: Hello. I'm Dr Leah Witt. Welcome to season one of Medscape InDiscussion, chronic obstructive pulmonary disease (COPD) podcast series. Today we're talking medications, especially ...
Statins are a class of drugs commonly used to lower bad cholesterol, but can they also treat obstructive airway diseases, such as asthma? UC Davis Health pulmonologists are exploring an innovative ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca announced it will expand the savings programs for its entire US inhaled respiratory portfolio, helping eligible patients pay no more than $35 per month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results